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A B S T R A C T
The use of silver nanoparticles (AgNPs) with their novel and distinct physical, chemical, and biological proper-
ties, has proven to be an alternative for the development of new antibacterial agents. In particular, the possibil-
ity to generate AgNPs coated with novel capping agents, such as phytomolecules obtained via a green synthesis
(G-AgNPs), is attracting great attention in scientific research.
Recently, we showed that membrane interactions seem to be involved in the antibacterial activity of AgNPs
obtained via a green chemical synthesis using the aqueous leaf extract of chicory (Cichorium intybus L.). Further-
more, we observed that these G-AgNPs exhibited higher antibacterial activity than those obtained by chemical
synthesis.
In order to achieve the green AgNPs mode of action as well as their cellular target, we aimed to study the an-
tibacterial activity of this novel green AgNPs against Gram-negative (Escherichia coli) and Gram-positive (Staphy-
lococcus aureus) bacteria. The effect of the G-AgNPs on the bacterial surface was first evaluated by zeta potential
measurements and correlated with direct plate count agar method. Afterwards, atomic force microscopy was ap-
plied to directly unravel the effects of these G-AgNPs on bacterial envelopes.
Overall, the data obtained in this study seems correlated with a multi-step mechanism by which electrostatic
interactions is the first step prior to membrane disruption, resulting in antibacterial activity.
1. Introduction
Nowadays, resistance to the main antibiotics currently used in the
clinic has been reaching a critical level, which has resulted in a sig-
nificant threat to public health [1–3]. One of the recent efforts in ad-
dressing this current scenario lies in reexploring the biological proper-
ties of already known antimicrobial materials by manipulating their size
to the nanoscale to which microbial pathogens may not be able to de-
velop resistance [4]. In this context, the silver-containing nanosystems,
notably silver nanoparticles (AgNPs), polymer/metal nanocomposites,
and magnetic nanostructures, have attracted great attention due to they
are one of the most promising nanostructures right now for the develop-
ment of new antibacterial agents, with potential applications in both the
pharmaceutical and biomedical fields as growth inhibitors, killing
agents, or antimicrobial carriers [5–13]. Thus, AgNPs impregnated in
biomedical materials, such as collagen, have shown biocompatibility
and enhanced antibacterial activity highlighting their potential utiliza-
tion for biomedical applications [8,9].
AgNPs are clusters of zero-valent silver with a size between 1 and
100nm, and an amount of surface atoms higher than in the bulk ma-
terial, whereby the scientific community and numerous technologies
take advantage of the unique physical, chemical, optical, and biolog-
ical properties of AgNPs for their use in catalysis, sensing, photonics,
electronics, and medical and pharmaceutical engineering [14,15]. Cur-
rently, advances in the field of nanotechnology have allowed the repro-
ducible synthesis of materials on a nanoscale using more eco-friendly
precursors and leave aside the traditional methodologies which often
generate toxic and/or flammable by-products that unavoidably trig-
ger the envi
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ronmental and safety issues [16,17]. In this regard, green synthesis pro-
tocols of AgNPs (G-AgNPs) provide an advancement over other methods
because they are simple, one step, cost-effective, environment friendly,
and relatively reproducible; moreover, they often result in more stable
nanomaterials [18]. Thus, green synthesis of AgNPs has been reported
using a variety of naturally occurring reagents such as microorganisms,
fungi, and especially plant extracts [19–22]. Furthermore, during green
synthesis, biological molecules present act not only as reducing agents,
but also as natural capping agents in replace of chemical ones. In addi-
tion, besides G-AgNPs and its chemically synthesized counterparts have
shown not much difference between their morphologies, G-AgNPs ex-
hibited much better antibacterial activity [23,24].
The antibacterial effect of silver-containing nanomaterials, such as
metallic AgNPs as well as nanoparticles of silver compounds, has been
reported by many researchers [25–27]. Although the highly antibac-
terial effect of AgNPs has been widely described, their mechanism of
action and effects on whole cells has not yet been fully elucidated.
In fact, the potent antibacterial and broad-spectrum activity of Ag-
NPs against morphologically and metabolically different microorgan-
isms seems to be correlated with a multifaceted mechanism [28]. It
was shown that silver-containing nanomaterials can: i) disrupt bacterial
metabolic processes [29,30], ii) interact with DNA [31], iii) increase the
cytoplasmic membrane permeability [32,33], and iv) generate oxidative
stress [34]. However, and in order to consider G-AgNPs as a therapeu-
tic option and overcome clinical setbacks, a worldwide work must be
done in order to unravel their mechanisms of action, as well as to man-
ufacture them cost-effectively on a large scale. In this context, in a pre-
vious work we showed that the interaction of AgNPs with lipid mem-
branes seems to be a critical step for the resulting antibacterial activity
of G-AgNPs coated with aromatic/hydrophobic moieties from chicoric
and chlorogenic acids, which were obtained via a green chemical syn-
thesis using an aqueous leaf extract of chicory (Cichorium intybus L.)
[24].
Therefore, the aim of this work was to gain information about the
mode of action of green nanosilver with chicoric/chlorogenic acid cap-
ping, as well as its cellular target, studying the interaction of these novel
G-AgNPs with whole bacteria using Escherichia coli and Staphylococcus
aureus as Gram-negative and Gram-positive models, respectively. Sur-
face characterization techniques, namely zeta potential and atomic force
microscopy (AFM), were used to i) correlate the G-AgNPs-bacteria at-
tachment with the resulting lethal activity, and ii) unravel the effects of
this nanomaterial on the bacterial envelope, respectively.
2. Material and methods
2.1. Synthesis of G-AgNPs
Green silver nanoparticles were synthesized employing an exper-
imental method similar to the previously reported [20]. Briefly, the
aqueous extract was prepared by decoction of leaf pieces (5g) of chicory
in 100mL of tridistilled water for 5min. The resultant extract was fil-
tered using a Whatman No. 1 filter paper. For the synthesis of G-Ag-
NPs, 50mL of 1mM AgNO⁠3 (Cicarelli, Argentina) were heated up to
80 °C. Once this temperature was reached, and solution, 5mL of pre-
viously obtained chicory leaf extract were added to the solution, with
stirring. During the reaction time of 15min, both temperature and ag-
itation remained constant. The formation of AgNPs was monitored by
UV–vis spectroscopy using a Hewlett Packard 8453 diode-array spec-
trophotometer.
2.2. Bacterial strains and growth conditions
E. coli ATCC 25929 and S. aureus ATCC 25923 were used in this work
to evaluate the interaction with the green nanoparticles. To carry out all
the tests, both strains were grown overnight in tryptic soy broth (TSB,
Britania, Buenos Aires, Argentina) at 37 °C. After incubation, an aliquot
of each culture was inoculated in fresh medium and incubated again un-
til reaching an optical density (OD) of 1.
2.3. Bacterial viability
The number of viable bacteria after 1h incubation with different
concentrations of G-AgNPs was quantified as colony forming units
(CFU). As a control, the viable count was also carried out when the
bacteria were incubated during the same time in growth medium with-
out the nanomaterial. Decimal dilutions were prepared from each of
the samples (with and without G-AgNPs) and plated on tryptic soy agar
(TSA). Plates were incubated at 37 °C for 18h and colonies counted. Vi-
ability was expressed as CFU/mL. The test was carried out in triplicate.
In addition, the antimicrobial activity of the chicory extract (with G-Ag-
NPs) was also tested against E. coli or S. aureus and no antibacterial ef-
fect for both strains was observed (see Supplementary data), which was
indicative that this effect was due to G-AgNPs.
2.4. Zeta potential
Zeta potential studies were performed at 25 °C on a Horiba SZ-100
nanoparticle analyzer (Horiba, Kyoto, Japan). Cell dilutions were pre-
pared using saline (NaCl 0.89% w/v). Bacterial suspensions were dis-
pensed into disposable zeta potential cells with gold electrodes and al-
lowed to equilibrate for 10min at 25 °C. Bacterial concentrations were
2×10⁠9 CFU/mL in order to acquire high enough count rates. For each
sample, the zeta potential was determined from the mean of 10 mea-
surements (500 runs each). The complete experiment was carried out in
triplicate for each sample, using independently grown cultures.
2.5. AFM imaging
Particle size analysis and morphological characterization of G-AgNPs
were done using a JPK NanoWizard IV atomic force microscope (Berlin,
Germany), mounted on a Zeiss Axiovert 200 inverted microscope (Jena,
Germany). Images were performed in intermittent contact mode in air,
using ACT silicon cantilevers (AppNano, Huntingdon, UK) with a nomi-
nal tip radius of 6nm, typical frequencies of 300kHz, and a spring con-
stant of 40N/m. All images were obtained with similar AFM settings (set
point, scan rate and gain). Height and error signals were collected and
images were analyzed with the JPK image processing software v. 6.0.55.
For bacterial surface characterization, the bacterial strains were treated
according to previous protocols [35–37]. Briefly, cell suspensions with
1×10⁠9 CFU/mL were spun down at 3000×g for 10min and washed
twice with 0.85% NaCl to remove the media. A 100μL droplet of each
sample was applied onto a glass slide and allowed to rest at 25 °C for
1h. After deposition, the sample was rinsed 10 times with Milli-Q water
and air-dried at 25 °C. On average, five individual bacterial cells were
imaged at high resolution for each sample.
2.6. Surface roughness
The data generated from the AFM height images were used to calcu-
late the surface quadratic roughness of the bacterial cell surface. Using
the Gwyddion software v. 2.19 (Czech Metrology Institute, Brno, Czech
Republic), the bacterial cell shape was estimated through the applica-
tion of a mean filter to the raw data. Subtraction of the treated image
from the original height image generated a flattened representation of
the bacterial cell surface. The surface roughness of a selected area of this
flattened image was then calculated from the height standard deviation,
i.e., the root-mean-square value (R⁠rms) of the height distribution, using
the following equation:
(1)
where N is the total number of data points, z⁠i is the height of the i-th
point, and z⁠m is the mean height [38]. Roughness values were measured
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2.7. Membrane leakage
Large unilamellar vesicles (LUVs) with approximately 100nm of di-
ameter were obtained by extrusion of multilamellar vesicles, as de-
scribed elsewhere [39]. 1-Palmitoyl-2-oleoyl-sn-glycero-3-phospho-
choline (POPC) and 1-palmitoyl-2-oleoyl-sn-glycero-3-phos-
pho-(1′-sn-glycerol) (POPG) were obtained from Avanti Polar Lipids (Al-
abaster, AL, USA). Phosphate buffer saline (PBS; 20mM sodium phos-
phate, 150mM NaCl) pH7.4 was used for all measurements. G-Ag-
NPs-induced lipid vesicle leakage was measured by fluorescence spec-
troscopy, as described previously, using a Varian Cary Eclipse fluores-
cence spectrophotometer (Mulgrave, Australia) [40–42]. In this assay,
the release of 5(6)-carboxyfluorescein (CF; Sigma, St. Louis, MO, USA)
entrapped into LUVs was monitored. LUVs with encapsulated CF were
prepared by hydrating the dried lipid film with PBS containing 100mM
CF (pH was adjusted to 7.4 with NaOH). Non-encapsulated CF was re-
moved by passing the suspension through an EconoPac 10 DG column
(Bio-Rad, Richmond, CA, USA) [40]. Aliquots of the liposomal stock
preparations (diluted to 10μM) were incubated with G-AgNPs at 25 °C.
Fluorescence was recorded continuously for 30min, with excitation at
492nm and emission at 517nm (5 and 10nm excitation and emission
slits, respectively). The rate of entrapped and released CF was estimated
by measuring the differences in the fluorescence emission at 517nm,
which increases upon CF-leakage from the vesicles. The data for 100%
of leakage (i.e. complete release of entrapped CF) was obtained at the
end of the experiment by the Triton X-100 addition to achieve a final
concentration of 1% [40–42].
2.8. Statistical analysis
Measurements were done in duplicate from three independent cul-
tures of each group studied. Analysis of variance (ANOVA) followed by
Dunnett post-test for multiple comparisons and Student's t-test were car-
ried out using the statistical software Graph Pad Prism. Data are shown
as the mean value.
3. Results and discussion
Bio-reduction of Ag⁠+ ions to colloidal nanoparticles was observed
by color change from colourless (AgNO⁠3 solution) to yellowish brown
(G-AgNPs) and confirmed by AFM. According to the previous results of
AgNPs biosynthesized from an aqueous leaf extract of Belgian endive, a
variety of Cichorium intybus L. [20], the bioactive molecules present in
the chicory extract used in this work, mainly chicoric and chlorogenic
acids [43], are expected to bind with metal surface, facilitate the for-
mation of a coat over the nanoparticles, and favour in stabilizing the
G-AgNPs against agglomeration. Thus, these phenolic compounds play
a dual role in the green synthesis of nanosilver acting both as reducing
and capping agents and allowing the formation of relatively homoge
nous spherical nanoparticles with an average diameter around 50nm, as
shown in Fig. 1, and a zeta potential of around −24mV. These results
are in a very good agreement with a previous characterization of these
G-AgNPs via transmission electron microscopy, dynamic light scattering,
and zeta potential, which were also spherical with an average hydrody-
namic diameter of 46nm and a polydispersion index of 0.39 indicating
a moderate distribution in the particles size, and had a zeta potential
between −27 and −17mV [24].
In a recent work [24], a biophysical analysis allowed us to probe that
green negatively charged-AgNPs can interact with model lipid mem-
branes and bind to a real bacterial membrane using whole E. coli bacte-
ria as a model. In this sense, and in order to get an inside in the interac-
tion with whole bacteria and its effects on cell viability, we studied the
surface alterations by zeta potential and cell viability by CFU/mL in E.
coli and S. aureus induced by G-AgNPs incubation. As it can be observed
in Fig. 2, zeta potential of both tested bacteria become more negative
after being incubated with increasing concentrations of G-AgNPs, which
is expected due to the negative zeta potential value of this nanomate-
rial. Beside both bacterial strains showed an increase in the negative
value of zeta potential, this effect becomes more noticeable in E. coli
(with a drop of zeta potential from (−30.1±0.1) mV for untreated cells
to (−34.3±0.8) mV with the highest concentration of G-AgNPs tested)
than S. aureus (with a shift from (−19.0±0.1) mV to (−21.0±0.7)
mV). Thus, and in a good correlation with zeta potential shift, a diminu-
tion of >1.6 log units was obtained in E. coli with the higher concen-
tration of nanomaterial tested (50 pM). On the other hand, only a drop
of 0.3 log units was achieved for S. aureus at the same concentration of
G-AgNPs. These results allow confirming a strong correlation of zeta po-
tential variation with bacterial damage, which is in a good agreement
with those previously reported where the zeta potential changes associ-
ated with damage in the structures of surface macromolecules and the
physiological state of cells [35,36,44].
hese results also reinforce the idea that the interaction of these
G-AgNPs with bacterial envelops seem be a critical step in the antibacte-
rial activity, as was previously reported [24]. This correlation between
membrane interaction and antibacterial activity could explained either
because the membrane is one the main target or by allowing the accu-
mulation of G-AgNPs, in that way increasing the local concentration of
silver that could lead to the bactericidal activity.
In order to evaluate the direct effect of G-AgNPs on the bacterial en-
velope, AFM was used as a tool to assess cell damage. AFM orthogonal
projections and error images are presented in Fig. 3. After 1h of incuba-
tion with G-AgNPs, several damages were observed in E. coli, together
with an increase in surface roughness and, in some cases, membrane
disruption and leakage of intracellular content (Fig. 3.2). Even though
previous transmission electron microscopy studies using chemical Ag-
NPs showed a similar envelope damage [45], it is important to point out
that a concentration 1000-fold lower was needed in the present study to
obtain comparable results.
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Fig. 2. Zeta potential values and CFU/mL of E. coli (2.1) or S. aureus (2.2) incubated with different concentrations of G-AgNPs in TSB media. Data represent the averages of three indepen-
dent measurements. Error bars indicate standard deviations of the mean values. ***p<.001; **p<.01; *p<.05. 1-way ANOVA followed by Dunnett post-test for multiple comparisons
versus control column (E. coli or S. aureus without G-AgNPs). Data obtained were fitted with a one-phase exponential decay model using the GraphPad Prism software.
As previously indicated, the aromatic/hydrophobic moieties from
the main phenolic compounds in chicory extract adsorbed on G-Ag-
NPs seem to promote the interactions with the hydrocarbon chain of
lipids, favouring a close contact of this nanomaterial with the lipid sur-
face [24,46,47], which could explain the strong antibacterial activity of
green AgNPs with respect to the chemically-obtained ones [24]. Some
structural alterations on S. aureus can be observed in Fig. 3.4; how-
ever, the changes on the cell surface were much less noticeable than
for E. coli, in good agreement with the zeta potential data showed in
Fig. 2.2. This divergence could be due to the structural and composi-
tion differences between the cell wall and membranes of Gram-positive
and Gram-negative bacteria, namely at the level of the thickness of the
peptidoglycan layer (S. aureus) and the presence of an outer membrane
containing lipopolysaccharides (E. coli) [48].
Additionally, a quantitative characterization of the damage exerted
by G-AgNPs incubation was carried out calculating the roughness of
the cell surface of both control and treated bacteria (Fig. 4). The sur-
face roughness of untreated E. coli cells was (1.04±0.01) nm and
(0.7±0.2) nm for S. aureus cells, which is in good agreement with pre-
viously published data [38]. As it can be seen in Fig. 4, the surface
roughness values were significantly affected in both bacterial strains
studied exposed to green nanosilver. However, the changes were more
noticeable in E. coli ((2.7±1) nm) than S. aureus ((1.6±0.7) nm) cells,
in good agreement with the zeta potential and AFM data shown above.
It is important to remark that future studies on the effect of these green
nanoparticles on other Gram-positive and Gram-negative bacteria are
necessary to evaluate their potential application as a new antibacterial
agent.
Overall, the results obtained demonstrate that G-AgNPs were able
to attach and disrupt the bacterial envelope, with a more noticeable ef-
fect on E. coli cells. One possible explanation for these findings is that
lipid membranes could be one of the targets of nanosilver, as reported
by other authors [28,49]. The fact that Gram-negative bacteria exhibit
an outer membrane may explain the major damage in comparison with
the Gram-positive S. aureus cells. Then, and in order to test this hypoth-
esis for the mode of action of these novel G-AgNPs, leakage experiments
were conducted in model lipid membranes (i.e., liposomes) employing
LUVs composed of POPC:POPG (5:1) as a model for the bacterial mem-
brane [50,51]. Interestingly, as shown in Fig. 5, no release of liposoma-
lly entrapped CF was observed, indicating that the G-AgNPs in a con-
centration similar to the tested in the AFM experiments were not able
to induce disruption effects on the model membrane system. Only after
the addition of 1% Triton X-100, CF entrapped was able to leak from the
liposomes in the external media.
The fact that a massive damage, especially in E. coli, was observed
by AFM in the cell envelope, including intracellular content leakage,
but no leakage was observed in the model membranes used, suggests
that in the mode of action of G-AgNPs should involve other phenom-
ena that lead to envelope damage. Although the interfacial interac-
tion of this nanomaterial with model lipid membranes causes no dis-
turbance per se of lipid packing, still remains as essential step for
the G-AgNPs accumulation on the cell envelope, acting as a
local silver reservoir or as a Trojan horse that via an oxidative dissolu-
tion proccess can release a high enough concentration of toxic Ag⁠+ ions
into or close to the bacterial cell [5]. Thus, the Ag⁠+ ions released may:
i) interact with thiol-containing proteins in the cell wall, affecting their
biological functions and cell permeability; ii) penetrate the cell wall and
enter into the cells, subsequently turning DNA into a condensed form;
and, iii) generate reactive oxygen species [5,52]. All these phenomena
can lead to cell envelope damage or even cell death. In this sense, a
study using E. coli confirmed that AgNPs accumulation on the cell mem-
brane creates gaps in the integrity of the bilayer, leading to a perme-
ability increase and finally bacterial cell death [49]. In this scenario,
it is important to highlight that recent research has shown that the re-
lease of Ag⁠+ ions from functionalized silver nanostructures can be con-
trolled more efficiently and ideally released fast enough to kill bacteria
but slowly enough to overcome the toxicity issue, mainly to the mam-
malian cells [9,16].
4. Conclusions
The findings of the present study lead to the conclusion that the po-
tent antibacterial and broad-spectrum activity of G-AgNPs against mor-
phologically and metabolically different microorganism correlates with
a multifaceted mechanism by which this nanomaterial induces bacter-
ial cell distortion and death. To the best of our knowledge, this is the
first study that gives direct evidences that G-AgNPs are able to induce
several damages on the bacterial envelope. This was achieved using sur-
face characterization techniques (zeta potential and AFM) and leakage
measurements. G-AgNPs accumulation on the bacterial membrane via
the primary AgNPs-lipid membrane interaction, without lipid packing
disruption, seem to be an essential step to the desired biological effect.
G-AgNPs immobilized on the bacterial surface may be able to produce a
Trojan horse effect, locally releasing high concentration of antibacterial
silver ions. Subsequently, the interaction of silver ions with macromole-
cule targets may cause alterations of cell morphology, interfere with the
DNA replication process, induce oxidative stress and, consequently, lead
to bacterial death. Therefore, the green synthesis technology represents
a promising approach for cost-effective and environmental-friendly pro-
duction of nanosilver, with enhanced antibacterial properties.
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.bbamem.2019.03.011.
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Fig. 3. AFM orthogonal projections (left) and AFM error images (right) of (3.1) E. coli in the absence of nanoparticles, (3.2) E. coli incubated 1h with 5 pM G-AgNPs, (3.3) S. aureus in the
absence of nanoparticles, and (3.4) S. aureus incubated 1h with 5 pM G-AgNPs.
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Fig. 4. Surface roughness (calculated based on the AFM images) of E. coli and S. aureus incubated 1h without and with 5 pM G-AgNPs. Data represent mean±standard deviation.
***p<.001, unpaired Student's t-test.
Fig. 5. Leakage of liposomes of POPC:POPG (5:1) in the presence of G-AgNPs. Liposome
suspension contained 0.1mM total phospholipid concentration and 5 pM of G-AgNPs, as a
function of time. Triton X-100 was added at 27min, in order to achieve 100% of leakage.
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The number of viable bacteria after 1h incubation with different
concentrations of G-AgNPs was quantified as colony forming units
(CFU). As a control, the viable count was also carried out when the
bacteria were incubated during the same time in growth medium with-
out the nanomaterial. Decimal dilutions were prepared from each of
the samples (with and without G-AgNPs) and plated on tryptic soy
agar (TSA). Plates were incubated at 37 °C for 18h and
colonies counted. Viability was expressed as CFU/mL. The test was
carried out in triplicate. In addition, the antimicrobial activity of the
chicory extract (with G-AgNPs) was also tested against E. coli or S.
aureus and no antibacterial effect for both strains was observed (see
Supplementary data), which was indicative that this effect was due to
G-AgNPs.
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